DavidAHendersonMD

PubMed

• 95 citations
  The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
  Thomas J. Povsic, Timothy D. Henry, Jay H. Traverse, F. David Fortuin, Gary L. Schaer, Dean J. Kereiakes, Richard A. Schatz, Andreas M. Zeiher, Christopher J. White, D...> ;JACC. Cardiovascular Interventions. 2016 Aug 8
• 12 citations
  Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Antico...
  Alon Eisen, Robert P. Giugliano, Christian T. Ruff, Francesco Nordio, Harinder S. Gogia, Vivek R. Awasty, David A. Henderson, Michele Mercuri, Howard Rutman, Elliott M...> ;American Heart Journal. 2016 Feb 1
• Lessons from the eradication of smallpox: an interview with D. A. Henderson.
  Henderson, D. A.,Klepac, P.> ;Philos. Trans. R. Soc. Lond., B, Biol. Sci.. 2013 Aug 5

Journal Articles

• A Novel Lead Design Reduces Far Field R-Waves (FFRWs) and Decreases the Incidence of Inappropriate Automatic Mode Switch Episodes.  
  Henderson, D.A, Heart Rhythm Journal
• REsponse to Ticagrclor in Clopidogrel Non-responders and ReSPONDers and the Effects of Switching Therapies: The RESPOND Study.  
  Henderson, D.A, Circulation

Abstracts/Posters

• Feasibility of Direct Coronary Blood Flow Measurements in Intact Human Subjects.
  Henderson, D.A. and Bowyer, A.F, West Virginia Medical Journal
• Hospital Cost Containment: A Little Knowledge Helps.
  Henderson, D.A, American Federation for Clinical Research, Spring Meeting, Washington, DC
• Pneumomediastinum As a Complication of Athletic Competition.
  Henderson, D.A. and Morgan, E.M, Thorax